January 18, 2022

Rates of cervical cancer screening have dropped in the U.S., with screening rates lowest among Asian and Hispanic women, as well as women who live in rural areas, don’t have insurance, or identify as LGBQ+, according to researchers with The University of Texas Health Science Center at Houston (UTHealth Houston).

January 13, 2022

Muhammad Haque, PhD, assistant professor of neurology with McGovern Medical School at UTHealth Houston and the UTHealth Institute for Stroke and Cerebrovascular Disease led a trial to investigate a special MRI protocol to help understand which patients might be at risk for hematoma expansion and determining when patients might be safely placed back on anti-thrombotic medications such as aspirin. 

January 12, 2022

A study designed to determine how magnetic resonance imaging (MRI) can be used to help clinicians treat patients with brain hemorrhages is underway at The University of Texas Health Science Center at Houston (UTHealth Houston).

January 11, 2022

An innovative academic drug discovery program at The University of Texas Health Science Center at Houston (UTHealth Houston) has earned Zhiqiang An, PhD, professor and director of the Texas Therapeutics Institute of the Brown Foundation Institute of Molecular Medicine at McGovern Medical School, a fellowship with the National Academy of Inventors (NAI).

January 5, 2022

For his research analyzing the time it takes to effectively administer anti-arrhythmic medication to cardiac arrest patients, Ryan Huebinger, MD, with The University of Texas Health Science Center at Houston (UTHealth Houston) has received the American Heart Association’s (AHA) Young Investigator Award.

December 20, 2021

 Maria E. Fernandez, PhD, the Lorne Bain Distinguished Professor in Public Health and Medicine, and professor of health promotion and behavioral science at UTHealth School of Public Health is the recipient of the 2022 Association of Schools and Programs of Public Health’s (ASPPH) Research Excellence Award. This distinguished award recognizes faculty who have devoted their careers to investigating public health issues. 

December 17, 2021

Krista Patlovich organized “Papou’s 5K” on Dec. 11 to honor her beloved father Nick Georgas, who died in December 2020 from COVID-19-related complications. The event raised more than $10,000 for COVID-19 research at UTHealth Houston.

December 16, 2021

Transgender men face significant health and social disparities, including barriers to health care, research, and essential HIV-related conversations with their health care providers. That is why Paige Wermuth, PhD, MPH, assistant professor in the Department of Management, Policy, and Community Health, and graduate student Lou Weaver of The University of Texas Health Science Center (UTHealth Houston) School of Public Health are launching a pilot project to examine and develop communication materials for trans men and their health care providers regarding HIV prevention.

December 16, 2021

Oropharyngeal cancer incidence among men is continuing to rise rapidly in nearly all 50 states and among women living in states in the Midwest and Southeast regions, according to a new study by investigators at The University of Texas Health Science Center at Houston (UTHealth Houston) School of Public Health in JAMA Otolaryngology-Head & Neck Surgery.

December 15, 2021

A nationwide effort to adequately vaccinate 8 in 10 adolescents against the human papillomavirus (HPV) could prevent 934,000 cases of virus-associated, male oropharyngeal cancer over this century, reported investigators at The University of Texas Health Science Center at Houston (UTHealth Houston) School of Public Health in The Lancet Regional Health—Americas.